The PARTNER B study has found transcatheter aortic valve replacement should be the standard of care for aortic stenosis patients who don't meet surgical criteria. "The ultimate value of TAVR in inoperable patients will depend on careful selection of patients who are not surgical candidates and do not have extreme comorbidities that overwhelm the benefits of TAVR and render the intervention futile," said interventional cardiologist and study presenter Dr. Raj Makkar.

Related Summaries